The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.

 
Web www.patentalert.com

< Replikin peptides in rapid replication of glioma cells and in influenza epidemics

< Antibodies which bind variants of the TRP channel family member, LTRPC3

> Fusion constructs containing active sections on TNF ligands

> Cellular targets for treatment of retroviral infection
~ 00601